The next step was to test the drugs in a living, breathing system: mice with glioblastoma.

With such promising pre-clinical results, additional trials in living human patients could reveal whether we may already have a glioblastoma therapy ready to fast-track. Researchers don't yet know whether the drug works in humans and what dose is required to combat the tumor,